top of page
News, Events and Updates
Search
Dec 30, 2014
Anavex Announces Fiscal 2014 Fourth Quarter and Year-End Financial Results
Dec 18, 2014
Anavex to Present at Biotech Showcase 2015 in San Francisco
Dec 16, 2014
Enrollment of Alzheimer's Patients in Phase 2a Clinical Trial of ANAVEX 2-73 and ANAVEX PLUS Begins
Dec 12, 2014
Anavex Upgrades to OTCQX Marketplace
Dec 11, 2014
Phase1 Dose Escalation Study to Investigate Safety, Tolerability, and Pharmacokinetics of ANAVEX2-73
Nov 17, 2014
Anavex Announces Positive Phase 1 Data for ANAVEX 2-73, Lead Candidate for Treatment of Alzheimer's
Nov 10, 2014
Anavex to Present Full Phase 1 Clinical Trial Data for ANAVEX 2-73 at CNS Summit 2014 Conference
Nov 6, 2014
Anavex to Present at SeeThruEquity Investor Conference in New York City
Nov 3, 2014
Anavex Receives Regulatory Approval to Initiate Phase 2a Clinical Trial of ANAVEX 2-73 & ANAVEX PLUS
Oct 26, 2014
Institutional Investor Lincoln Park Capital Increases Ownership in Anavex, Pays Over 25% Premium
Sep 7, 2014
Anavex Supports Alzheimer's Founding of America's 3rd Annual Concepts in Care Educational Conference
35
36
37
38
39
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
